228 related articles for article (PubMed ID: 1386767)
1. Refractory peptic ulcers.
Arakawa T; Kobayashi K; Dajani EZ
J Assoc Acad Minor Phys; 1992; 3(3):95-102. PubMed ID: 1386767
[TBL] [Abstract][Full Text] [Related]
2. Drugs for treatment of peptic ulcers.
Dajani EZ; Trotman BW
J Assoc Acad Minor Phys; 1992; 3(3):78-88. PubMed ID: 1353999
[TBL] [Abstract][Full Text] [Related]
3. Medical treatment of peptic ulcers.
Deveney CW; Deveney KE
Surg Annu; 1985; 17():219-33. PubMed ID: 3883541
[TBL] [Abstract][Full Text] [Related]
4. [H2-blocker refractory ulcers: what can be done?].
Dammann HG
Z Gastroenterol; 1992 Apr; 30(4):268-71. PubMed ID: 1351328
[TBL] [Abstract][Full Text] [Related]
5. Current trends in the pharmacotherapy for peptic ulcer disease.
Hixson LJ; Kelley CL; Jones WN; Tuohy CD
Arch Intern Med; 1992 Apr; 152(4):726-32. PubMed ID: 1558429
[TBL] [Abstract][Full Text] [Related]
6. The therapeutic efficacy of misoprostol in peptic ulcer disease.
Watkinson G; Hopkins A; Akbar FA
Postgrad Med J; 1988; 64 Suppl 1():60-77. PubMed ID: 3138682
[TBL] [Abstract][Full Text] [Related]
7. Current concepts in clinical therapeutics: peptic ulcer disease.
Siepler JK; Mahakian K; Trudeau WT
Clin Pharm; 1986 Feb; 5(2):128-42. PubMed ID: 2869852
[TBL] [Abstract][Full Text] [Related]
8. Study of outcome after targeted intervention for peptic ulcer resistant to acid suppression therapy.
Lanas A; Remacha B; Sáinz R; Hirschowitz BI
Am J Gastroenterol; 2000 Feb; 95(2):513-9. PubMed ID: 10685760
[TBL] [Abstract][Full Text] [Related]
9. Non-steroidal anti-inflammatory drug gastropathy: clinical results with H2 antagonists and proton pump inhibitors.
Lazzaroni M; Bianchi Porro G
Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S73-8. PubMed ID: 10379473
[TBL] [Abstract][Full Text] [Related]
10. NSAID-induced gastrointestinal damage. A critical review of prophylaxis and therapy.
McCarthy DM
J Clin Gastroenterol; 1990; 12 Suppl 2():S13-20. PubMed ID: 1978842
[TBL] [Abstract][Full Text] [Related]
11. Topically active drugs in the treatment of peptic ulcers. Focus on colloidal bismuth subcitrate and sucralfate.
Bianchi Porro G; Parente F
J Clin Gastroenterol; 1992 Apr; 14(3):192-8. PubMed ID: 1348753
[TBL] [Abstract][Full Text] [Related]
12. Overview of medical therapy of peptic ulcer disease.
Freston JW
Gastroenterol Clin North Am; 1990 Mar; 19(1):121-40. PubMed ID: 2184124
[TBL] [Abstract][Full Text] [Related]
13. An etiologic approach to management of duodenal and gastric ulcers.
Rex DK
J Fam Pract; 1994 Jan; 38(1):60-7. PubMed ID: 8289053
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
Park KN; Hahm JS; Kim HJ
Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in the treatment of digestive diseases.
Sun HS
J Int Med Res; 1989; 17 Suppl 1():2A-8A. PubMed ID: 2566540
[TBL] [Abstract][Full Text] [Related]
16. Prevention and treatment of ulcers induced by nonsteroidal anti-inflammatory drugs: an update.
Dajani EZ; Agrawal NM
J Physiol Pharmacol; 1995 Mar; 46(1):3-16. PubMed ID: 7599335
[TBL] [Abstract][Full Text] [Related]
17. Omeprazole in acute and long-term treatment of Asian patients with peptic ulcer refractory to H2-antagonists.
Chelvam P; Wong EC
J Gastroenterol Hepatol; 1989; 4 Suppl 2():75-81. PubMed ID: 2577478
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological and pharmacodynamic essentials of H(2)-receptor antagonists and proton pump inhibitors for the practising physician.
Huang JQ; Hunt RH
Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):355-70. PubMed ID: 11403532
[TBL] [Abstract][Full Text] [Related]
19. Prevention and treatment of gastrointestinal symptoms and complications due to NSAIDs.
McCarthy DM
Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):755-73. PubMed ID: 11566039
[TBL] [Abstract][Full Text] [Related]
20. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
Florent C
Clin Ther; 1993; 15 Suppl B():14-21. PubMed ID: 7911399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
